市场调查报告书
商品编码
1465069
病理资讯学市场:按产品类型、应用和最终用户划分 - 全球预测 2024-2030Pathology Informatics Market by Product Type, Application, End-User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年病理资讯学市场规模为13.3亿美元,预计2024年将达到14.4亿美元,2030年将达到22.9亿美元,复合年增长率为7.98%。
病理资讯学是一个交叉学科领域,专注于应用资讯科技来收集、储存、分析和普及病理资料。这包括管理与病理学领域的患者护理、研究和教育活动相关的资讯。这包括各种主题,包括实验室资讯系统 (LIS)、病理标本的数位成像和分析、资料探勘和管理、互通性和标准化以及远端病理学。慢性病的增加需要病理资讯学等先进的诊断技术。此外,对高效实验室管理系统处理不断增加的病理资料的需求不断增长,正在扩大病理资讯学的范围。对需要详细病理分析的个人化医疗和标靶治疗的日益关注正在扩大病理资讯学的应用。然而,数位病理系统和相关基础设施的初始投资成本较高,加上缺乏病理学和资讯学方面的熟练专业人员,为市场成长带来了挑战。然而,用于预测分析和提高诊断准确性的人工智慧和机器学习模型的市场开拓为市场成长提供了机会。病理资讯学系统已整合到医疗保健 IT 生态系统中,以实现全面的患者照护,扩大了病理资讯学解决方案的采用范围。
主要市场统计 | |
---|---|
基准年[2023] | 13.3亿美元 |
预测年份 [2024] | 14.4亿美元 |
预测年份 [2030] | 22.9亿美元 |
复合年增长率(%) | 7.98% |
数位病理系统普及,提升慢性病诊断准确性
数位病理学系统是病理学资讯学的新兴类别,主要用于储存、管理和分析从玻片扫描获得的数位影像。这些系统正在彻底改变传统的病理学工作流程,提供更高的诊断准确性、远端存取玻片以及跨地理边界的协作机会。数位病理学系统的采用正在强劲增长,特别是随着对高效诊断技术的需求不断增加以及慢性病患病率的上升。实验室资讯管理系统 (LIMS) 是一种软体解决方案,透过管理资料、工作流程和通讯来简化实验室业务。它自动执行检体管理、测试、结果分析和合规管理等任务,在确保实验室效率和有效性方面发挥关键作用。 LIMS 具有高度适应性,可用于医疗保健以外的各种行业,例如环境、製药和生物技术。实验室资讯系统 (LIS) 专门用于临床实验室,专注于管理患者资料、实验室工作流程和诊断资讯。与可适应更广泛实验室类型的 LIMS 不同,LIS 专门支援临床诊断并提供用于订单输入、结果输入、检体追踪和患者统计的工具。病理影像处理软体支援病理影像的可视化、解释和分析。它允许病理学家使用缩放、平移和註释工具在电脑上检查幻灯片影像,从而在数位病理诊断中发挥重要作用。该软体透过先进的影像分析技术(包括用于模式识别的机器学习演算法)提高诊断准确性。对病理影像处理软体的需求是由促进远距离诊断、教育和协作研究的功能所驱动的。病理资讯学工作流程管理解决方案旨在优化实验室业务、减少人工错误并缩短週转时间。这些解决方案管理从检体接受到结果交付的整个工作流程,确保所有流程快速且有效率地完成。它对于标准化业务、减少浪费和提高实验室整体生产力至关重要。实验室业务的增加和无缝整合业务的需求是采用工作流程管理解决方案的关键驱动力。
最终用户:诊断实验室采用率高,可有效管理大量资料
诊断实验室是病理资讯学的关键最终用户,利用复杂的系统有效管理大量资料。这些实验室越来越多地实施数位病理学解决方案,以简化工作流程、提高诊断准确性并缩短週转时间。病理资讯学整合可以轻鬆储存、搜寻和分析病理资料和影像,方便远端检查和第二意见。医院和诊所依靠病理资讯学来提供更快、更准确的诊断服务并改善患者照护。即时存取病理资料和影像有利于多学科检查和决策流程,极大地受益于病理数位化。此外,将病理资料整合到电子健康记录系统中可以为医疗保健提供者提供患者健康史的全面视图,从而提高护理的连续性。研究机构和学术中心处于利用病理资讯学推进医学研究和教育的前沿。这些机构利用复杂的资料分析工具和计算演算法对疾病模式、治疗结果和流行病学趋势进行大规模研究。病理标本的数位化也有助于跨机构共用罕见病例和教育资源,促进协作研究和学习。
区域洞察
以美国和加拿大为中心的美洲地区因其完善的医疗基础设施、强大的数位化倡议以及对研发的高度重视而成为病理资讯学的重要市场。数位病理系统的引入,加上人工智慧和机器学习演算法的引入,正在推动市场向前发展。由于医疗保健系统、法规环境和技术采用水准的不同,欧洲、中东和非洲地区的市场是异质的。西欧在市场成熟度方面处于领先地位,并且正在经历数位病理学的强劲增长。同时,由于医疗成本上升和数位转型倡议,中东和非洲成为具有潜力的新兴市场。由于人口众多、慢性病数量不断增加以及医疗保健产业快速发展,亚太地区的病理资讯学呈现快速成长。中国、日本和澳洲等国家处于采用数位病理解决方案的前沿,以满足对先进诊断服务不断增长的需求。
FPNV定位矩阵
FPNV 定位矩阵对于评估病理资讯学市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对病理资讯学市场中供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4. 竞争评估和情报:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1.病理资讯学市场的市场规模和预测是多少?
2.在病理资讯学市场的预测期内,有哪些产品、细分市场、应用程式和领域需要考虑投资?
3.病理资讯学市场的技术趋势和法规结构是什么?
4.病理资讯学市场主要供应商的市场占有率是多少?
5. 进入病理资讯学市场的合适型态和策略手段是什么?
[190 Pages Report] The Pathology Informatics Market size was estimated at USD 1.33 billion in 2023 and expected to reach USD 1.44 billion in 2024, at a CAGR 7.98% to reach USD 2.29 billion by 2030.
Pathology informatics is a multidisciplinary field that focuses on the application of information technology to the collection, storage, analysis, and dissemination of pathology data. This includes the management of information related to patient care, research, and educational endeavors within the realm of pathology. It includes a range of topics, including laboratory information systems (LIS), digital imaging and analysis of pathology specimens, data mining and management, interoperability and standards, and telepathology, among others. The increasing prevalence of chronic diseases necessitates advanced diagnostic techniques such as pathology informatics. Moreover, the rising demand for efficient laboratory management systems to cope with the expanding volume of pathology data has created added scope for pathology informatics. Enhanced focus on personalized medicine and targeted therapies, requiring detailed pathological analysis, expand the applications for pathology informatics. However, high initial investment costs for digital pathology systems and related infrastructure, coupled with the scarcity of skilled professionals proficient in both pathology and informatics, challenge the growth of the market. Nevertheless, the development of AI and machine learning models for predictive analytics and improved diagnostic accuracy provides an opportunistic view for market growth. Integration of pathology informatics systems within broader healthcare IT ecosystems for holistic patient care created an expanded scope for the adoption of pathology informatics solutions.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 1.33 billion |
Estimated Year [2024] | USD 1.44 billion |
Forecast Year [2030] | USD 2.29 billion |
CAGR (%) | 7.98% |
Type: Proliferation of digital pathology systems for enhanced diagnostic accuracy against rising chronic diseases
Digital Pathology Systems are an emergent category within pathology informatics, primarily designed for storing, managing, and analyzing digital images obtained from slide scans. These systems have revolutionized the traditional pathology workflow, offering enhanced diagnostic accuracy, remote access to slides, and collaborative opportunities across geographic boundaries. The adoption of digital pathology systems has seen significant growth, especially with the increased demand for efficient diagnostic techniques and the rising prevalence of chronic diseases. Laboratory Information Management Systems (LIMS) are software solutions that streamline laboratory operations by managing data, workflows, and communications. They are critical in ensuring the efficiency and effectiveness of laboratories, automating tasks such as sample management, testing, results analysis, and compliance management. LIMS are highly adaptable, catering to various industries beyond healthcare, including environmental, pharmaceutical, and biotechnology. Laboratory Information Systems (LIS) are tailored specifically for the clinical laboratory sector, focusing on managing patient data, laboratory workflow processes, and diagnostic information. Unlike LIMS, which can serve a broader range of laboratory types, LIS specifically supports clinical diagnostics, providing tools for order entry, result entry, specimen tracking, and patient demographics. Pathology Imaging Software supports the visualization, interpretation, and analysis of pathology images. It plays a crucial role in digital pathology by enabling pathologists to examine slide images on computers with zooming, panning, and annotating tools. This software enhances diagnostic accuracy through advanced image analysis techniques including machine learning algorithms for pattern recognition. The demand for pathology imaging software is rising, attributed to its capability to facilitate remote diagnostics, teaching, and collaborative research. Workflow management solutions in pathology informatics are designed to optimize laboratory operations, reduce manual errors, and improve turnaround times. These solutions manage the entire workflow from specimen receipt to result delivery, ensuring that all processes are completed promptly and efficiently. They are integral in standardizing operations, reducing waste, and enhancing overall laboratory productivity. Increasing laboratory workload and the need for seamlessly integrated operations are significant drivers for adopting workflow management solutions.
End-User: High adoption in diagnostic laboratories to manage a vast amount of data efficiently
Diagnostic laboratories represent a pivotal end-user in pathology informatics, utilizing advanced systems to manage a vast amount of data efficiently. These laboratories are increasingly adopting digital pathology solutions to streamline workflow, enhance diagnostic accuracy, and improve turnaround times. The integration of pathology informatics allows for better storage, retrieval, and analysis of pathological data and images, facilitating remote consultations and second opinions. Hospitals and clinics utilize pathology informatics mainly to enhance patient care through faster and more accurate diagnostic services. These settings benefit significantly from the digitization of pathology as it enables real-time access to pathological data and images, facilitating multidisciplinary consultations and decision-making processes. Additionally, the integration of pathology data into the electronic health record systems improves the continuity of care by facilitating healthcare providers with a comprehensive view of patient health history. Research institutes and academic centers are at the forefront of utilizing pathology informatics for the purpose of advancing medical research and education. These entities leverage sophisticated data analysis tools and computational algorithms to conduct large-scale studies on disease patterns, treatment outcomes, and epidemiological trends. The digitization of pathology specimens also facilitates the sharing of rare cases and educational resources across institutions, promoting collaborative research and learning.
Regional Insights
The Americas region, particularly the United States and Canada, represents a significant market for Pathology Informatics, driven by well-established healthcare infrastructure, robust digitization initiatives, and a strong focus on research and development. The adoption of digital pathology systems, coupled with the infusion of AI & machine learning algorithms, has propelled the market forward. The market in the EMEA region shows variability due to diverse healthcare systems, regulatory environments, and levels of technology adoption. Western Europe leads in market maturity, with considerable growth in digital pathology, whereas the Middle East and Africa are emerging markets with potential due to increasing healthcare expenditure and digital transformation initiatives. The Asia Pacific region showcases rapid growth for Pathology Informatics due to its large population base, increasing incidence of chronic diseases, and rapidly evolving healthcare sector. Countries including China, Japan, and Australia are at the forefront of adopting digital pathology solutions to meet the growing demand for advanced diagnostic services.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Pathology Informatics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Pathology Informatics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Pathology Informatics Market, highlighting leading vendors and their innovative profiles. These include 3DHISTECH Ltd., Abbott Laboratories, Agilent Technologies, Inc., Aiforia Technologies PLC, Capgemini SE, Clinisys, Inc., Corista LLC, Danaher Corporation, F. Hoffmann-La Roche AG, GE Healthcare, Huron Digital Pathology, Illumina, Inc., Indica Labs, Infosys Limited, International Business Machines Corporation, Koninklijke Philips N.V., Meteor Biotech., Olympus Corporation, OptraSCAN, Inc., Paige AI, Inc., PathAI, PerkinElmer Inc., Proscia Inc., Scitara Corporation, Siemens Healthineers, Thermo Fisher Scientific, Inc., and Xybion Digital Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Pathology Informatics Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Pathology Informatics Market?
3. What are the technology trends and regulatory frameworks in the Pathology Informatics Market?
4. What is the market share of the leading vendors in the Pathology Informatics Market?
5. Which modes and strategic moves are suitable for entering the Pathology Informatics Market?